Abstract:Glioblastoma (GBM) is the most common malignant primary tumor in the human central nervous system. The present study aimed to explore the molecular mechanism by which microRNA (miR)-181a-5p targets the F-box protein 11 (FBXO11) in glioma cells to inhibit cell proliferation and invasion. Reverse transcription-quantitative (RT-q)PCR was performed to detect the expression levels of miR-181a-5p in U251TR cells, U251 cells, primary GBM tissues and relapsed GBM tissues in order to determine the association between miR-181a-5p and the chemoresistance of GBM cells. The expression levels of miR-181a-5p in GBM cells were modulated via transfecting miR-181a-5p mimics and inhibitors. Cell Counting Kit-8 assays were undertaken to assess the effects of miR-181a-5p on drug sensitivity and proliferation of GBM cells. Wound healing assays were performed to examine the effects of miR-181a-5p on the migratory ability of GBM cells. Furthermore, the effects of miR-181a-5p on the invasive ability of GBM cells were analyzed using an in vitro invasion assay. Flow cytometry analysis was carried out to determine whether overexpression of miR-181a-5p can promote the apoptotic rate of GBM cells. RT-qPCR and western blotting were employed to detect the effects of miR-181a-5p on mRNA and protein expression of FBX011. miR-181a-5p exhibited low expression in resistant GBM cell lines and recurrent tumor tissues. Dual-luciferase reporter assays were utilized to detect luciferase activity to verify the targeted regulatory association between miR-181a-5p and FBXO11. Upregulation of miR-181a-5p promoted the sensitivity of GBM cells to temozolomide (TMZ), increased the apoptotic rate of GBM cells and significantly inhibited the invasive and migratory capacities of GBM cells. In drug-resistant glioma cells, compared with the miR-negative control group and the blank group, the expression of miR-181a-5p was significantly upregulated (P<0.01), while the expression of FBXO11 protein was downregulated. miR-181a-5p increased the sensitivity of GBM cells to TMZ. miR-181a-5p significantly inhibited the migratory and invasive capacities of GBM cells. miR-181a-5p may become a novel effective target for the treatment of GBM. The results of dual-luciferase reporter assays indicated that miR-181a-5p could target the 3'-untranslated region of FBXO11. The underlying mechanism may be targeted inhibition of FBXO11 gene expression, or may be associated with apoptosis.

MicroRNA-184 Inhibits Cell Proliferation and Invasion, and Specifically Targets TNFAIP2 in Glioma

[Down-Regulation of Lncrna TTTY15 Targeting Mir-4500 to Inhibit the Biological Characteristics of A172 Glioma Cells].

miR-19b-3p inhibits glioma progression via interacting with lncRNA HAGLR

MicroRNA-181 Inhibits Glioma Cell Proliferation by Targeting Cyclin B1.

MicroRNA‑218 Inhibits the Malignant Phenotypes of Glioma by Modulating the TNC/AKT/AP‑1/TGFβ1 Feedback Signaling Loop

MicroRNA-16 Inhibits Glioma Cell Growth and Invasion Through Suppression of BCL2 and the Nuclear Factor-Κb1/mmp9 Signaling Pathway.

Microrna-138 Modulates Glioma Cell Growth, Apoptosis And Invasion Through The Suppression Of The Akt/Mtor Signalling Pathway By Targeting Creb1

MicroRNA-181b Inhibits Cellular Proliferation and Invasion of Glioma Cells Via Targeting Sal-Like Protein 4.

MicroRNA-509-3p Inhibits Cell Proliferation and Invasion Via Downregulation of X-linked Inhibitor of Apoptosis in Glioma.

MicroRNA-140-5p Inhibits Cell Proliferation and Invasion by Regulating VEGFA/MMP2 Signaling in Glioma

MicroRNA-218 Modulates Activities of Glioma Cells by Targeting HMGB1.

MicroRNA-218 inhibits glioma invasion,mi-gration,proliferation,and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1

Inhibitory Effect of Mir-184 on the Potential of Proliferation and Invasion in Human Glioma and Breast Cancer Cells in Vitro.

MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.

microRNA-200a functions as a tumor suppressor by targeting FOXA1 in glioma.

Mir-181A-5p Inhibits the Proliferation and Invasion of Drug-Resistant Glioblastoma Cells by Targeting F-box Protein 11 Expression

MicroRNA-1468-5p Inhibits Glioma Cell Proliferation and Induces Cell Cycle Arrest by Targeting RRM1.

[Inhibitory Effect of Knocking Down Microrna-221 and Microrna-222 on Glioma Cell Growth in Vitro and in Vivo].

MicroRNA-409-3p Represses Glioma Cell Invasion and Proliferation by Targeting High-Mobility Group Nucleosome-Binding Domain 5.

MicroRNA-338-5p Plays a Tumor Suppressor Role in Glioma Through Inhibition of the MAPK-signaling Pathway by Binding to FOXD1

microRNA-155 regulates cell proliferation and invasion by targeting FOXO3a in glioma.